Left Ventricular Assist Device Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Left Ventricular Assist Device Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Left Ventricular Assist Device Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising prevalence of cardiovascular diseases
5.1.2 Increase in minimally invasive procedures

5.2 Market Opportunities

5.2.1 Growth in heart failure treatment options
5.2.2 Expansion in outpatient and ambulatory care

5.3 Future Trends

5.3.1 Development of more compact and efficient devices
5.3.2 Use of AI for real-time monitoring

5.4 Impact of Drivers and Restraints

6. North America Left Ventricular Assist Device Market Regional Analysis

6.1 North America Left Ventricular Assist Device Market Overview

6.2 North America Left Ventricular Assist Device Market Revenue 2020-2028 (US$ Million)

6.3 North America Left Ventricular Assist Device Market Forecast Analysis

7. North America Left Ventricular Assist Device Market Analysis – by Type of Flow

7.1 Pulsatile Flow

7.1.1 Overview
7.1.2 Pulsatile Flow: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Non-Pulsatile Flow

7.2.1 Overview
7.2.2 Non-Pulsatile Flow: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Left Ventricular Assist Device Market Analysis – by Design

8.1 Implantable Ventricular Assist Devices

8.1.1 Overview
8.1.2 Implantable Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Transcutaneous Ventricular Assist Devices

8.2.1 Overview
8.2.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Left Ventricular Assist Device Market Analysis – by Application

9.1 Bridge to Transplantation

9.1.1 Overview
9.1.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Destination Therapy

9.2.1 Overview
9.2.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Bridge to Recovery

9.3.1 Overview
9.3.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Bridge to Candidacy

9.4.1 Overview
9.4.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Left Ventricular Assist Device Market – North America Analysis

10.1 North America

10.1.1 North America Left Ventricular Assist Device Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 North America Left Ventricular Assist Device Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
10.1.1.1.2 US: North America Left Ventricular Assist Device Market Breakdown, by Design
10.1.1.1.3 US: North America Left Ventricular Assist Device Market Breakdown, by Application

10.1.1.2 Canada: North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
10.1.1.2.2 Canada: North America Left Ventricular Assist Device Market Breakdown, by Design
10.1.1.2.3 Canada: North America Left Ventricular Assist Device Market Breakdown, by Application

10.1.1.3 Mexico : North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
10.1.1.3.2 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Design
10.1.1.3.3 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Left Ventricular Assist Device Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ABIOMED Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Abbott Laboratories

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Medtronic Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 LivaNova Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Terumo Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Berlin Heart GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 BiVACOR Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Evaheart Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 BioVentrix Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights